TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
VTRS

Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.70$ -2.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 2,316 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VTRS
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
47 53 163 119 67 346 313 226 204 417 390 168 384 605 931 720 949 1,107 1,015 2,009 2,047 2,065 2,342 1,804 1,232 3,017 2,953 2,800 2,303 2,316
17 22 27 36 42 46 41 44 45 47 62 210 425 401 423 494 547 498 539 1,100 1,491 1,728 1,889 2,019 2,216 4,507 3,028 2,741 2,709 2,798
– 4.1 44 38 – – – – 128 79 -0.6 – 31 31 31 43 43 47 66 93 89 75 -71 57 79 111 116 181 146 178
– – – – – – – – – – – – – – – – – – – – 886 323 290 456 703 2,877 -1,058 – – –
-39 -72 -12 -92 -37 -3.6 -90 -114 -144 114 -35 -52 -191 -264 -142 -470 -673 -625 -552 -299 -935 -712 -385 -508 -696 -1,805 -923 -711 -319 -2,504
27 29 17 29 25 21 33 118 91 104 162 111 165 154 193 280 305 335 325 363 390 276 252 406 681 509 443 475 326 379
– – – – – – – -250 -175 195 – -7,035 -153 -328 -750 -347 -371 -1,869 -800 -1,570 -7,678 -976 -1,210 -525 -301 -118 1,521 -764 1,801 -428
20 20 20 21 20 20 21 26 32 50 51 30 137 139 139 – – – – – – – 399 0.3 7.9 399 582 576 575 561
– -2.5 – – -91 – -241 -133 – -1,258 – – – – – -350 -1,000 -1,000 -28 -68 -18 -500 -432 -8.4 -7.9 -17 -17 -250 -250 -501
– – – – – – – – – – – – – – – – – – – – 5,497 -1,360 -632 -1,103 -401 -2,099 -3,280 -1,250 -3,714 0.1
-38 -39 -24 -33 -112 -7.4 -231 -132 -2.6 -599 1,443 6,069 -167 -454 100 -645 -612 693 -267 605 5,345 -1,893 -1,091 -1,169 -606 -3,012 -3,878 -2,302 -4,330 -1,294
-51 -22 86 14 26 -68 98 -157 36 12 1,102 334 113 -169 258 -302 -34 -59 -66 1,011 -89 -777 19 102 359 -144 556 -269 -258 612
20 24 147 90 42 326 281 107 113 313 228 57 219 451 739 441 644 772 690 1,646 1,657 1,789 2,090 1,398 551 2,508 2,510 2,325 1,977 1,937

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?